EWTX Aug 2024 17.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

4.0400

-0.3600

(-8.18%)

At close: 09:58AM EDT

Loading interactive chart…

GuruFocus.com
Edgewise Therapeutics Inc (EWTX) Reports First Quarter 2024 Financial Results
Performance Analysis and Future Clinical Prospects
Business Wire
Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024
BOULDER, Colo., May 10, 2024--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 15, 2024, at 3:35 pm ET.
Business Wire
Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
BOULDER, Colo., May 09, 2024--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the first quarter of 2024 and recent business highlights.